Advertisement

18F-FDG and Non-FDG PET Radiopharmaceuticals

  • James Ballinger
  • Gopinath Gnanasegaran
Chapter
Part of the Clinicians’ Guides to Radionuclide Hybrid Imaging book series (CGRHI)

Abstract

Positron emission tomography/computed tomography (PET/CT) is one of the key imaging techniques in oncology. Hybrid PET/CT provides both structural and metabolic information and in general improves sensitivity, specificity, and reporter confidence.

Keywords

Sodium Fluoride Glucose Analogue Metabolic Information Principal Route Increase Glucose Utilisation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Torizuka T, Tamaki N, Inokuma T, et al. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med. 1995;36:1811–7.PubMedGoogle Scholar
  2. 2.
    Cook GJR, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18F-FDG PET scanning: potential for error in interpretation. Semin Nucl Med. 1996;26:308–14.CrossRefPubMedGoogle Scholar
  3. 3.
    Warburg O. On the origin of cancer cells. Science. 1956;123:309–14.CrossRefPubMedGoogle Scholar
  4. 4.
    Cook GJR, Maisey MN, Fogelman I. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18F-fluoro-2-deoxyglucose and carbon-11-methionine. Eur J Nucl Med. 1999;26:1363–78.CrossRefPubMedGoogle Scholar
  5. 5.
    Culverwell AD, Scarsbrook AF, Chowdhury FU. False-positive uptake on 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging. Clin Radiol. 2011;66:366–82.CrossRefPubMedGoogle Scholar
  6. 6.
    Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics. 1999;19:61–77.CrossRefPubMedGoogle Scholar
  7. 7.
    Delbeke D, Coleman RE, Guiberteau MJ, et al. Procedure guideline for tumour imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47:885–95.PubMedGoogle Scholar
  8. 8.
    Boellaard R, O’Doherty MJ, Weber WA, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37:181–200.CrossRefPubMedGoogle Scholar
  9. 9.
    Segall G, Delbeke D, Stabin MG, et al. SNM practice guideline for sodium 18F-fluoride PET/CT bone scans 1.0. J Nucl Med. 2010;51:1813–20.CrossRefPubMedGoogle Scholar
  10. 10.
    Virgolini I, Ambrosini V, Bomanji JB, et al. Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. Eur J Nucl Med Mol Imaging. 2010;37:2004–10.CrossRefPubMedGoogle Scholar
  11. 11.
    Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med. 2006;2(354):496–507.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Division of Imaging SciencesKing’s College LondonLondonUK
  2. 2.Department of Nuclear MedicineRoyal Free London NHS Foundation TrustLondonUK

Personalised recommendations